Back

Amyloid: nuclear is king.

8 May 2021 (10:50 - 11:00)
Organised by:
Congress Presentation Part of: Cardiovascular magnetic resonance vs nuclear in amyloidosis and inflammation Diagnostic Methods EACVI Premium Access EuroCMR 2021

About the speaker

Photo
Doctor Alessia Gimelli

Toscana Gabriele Monasterio Foundation, Pisa (Italy)

4 More presentations in this session

Presentation thumbnail
Sarcoidosis: positron emission tomography (PET) is king.
Doctor S. Dorbala (Boston, US)
Slides Video
Presentation thumbnail
Sarcoidosis: CMR is king.
Doctor A. Patel (Charlottesville, US)
Slides Video
Presentation thumbnail
Amyloid: CMR is king.
Professor M. Fontana (London, GB)
Slides Video
Presentation thumbnail
Cardiovascular magnetic resonance vs nuclear in amyloidosis and inflammation - discussion.

Access the full session

Session thumbnail
Cardiovascular magnetic resonance vs nuclear in amyloidosis and inflammation
Video

The Event

Event poster

EuroCMR 2021

8 May 2021 10:50 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac amyloidosis: what can nuclear offer?
12 December 2025
thumbnail
Congress Presentation
Prognostication of cardiac amyloidosis by pittsburgh b compound positron emission tomography
28 August 2020
thumbnail
Webinar
New drugs in the treatment of amyloidosis
16 July 2025
thumbnail
Webinar
The role of cardiac imaging for assessment of specific patient populations, according to new 2022 ESC Guidelines on Cardio-Oncology.
13 January 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources